Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P15
Within normal range
vs 3Y Ago
-1.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -67.69% |
| Q2 2025 | 55.96% |
| Q1 2025 | -42.40% |
| Q4 2024 | 10.63% |
| Q3 2024 | 43.85% |
| Q2 2024 | 0.85% |
| Q1 2024 | 24.25% |
| Q4 2023 | -19.75% |
| Q3 2023 | 18.74% |
| Q2 2023 | -77.36% |
| Q1 2023 | 31.65% |
| Q4 2022 | 25.56% |
| Q3 2022 | 41.44% |
| Q2 2022 | -41.91% |
| Q1 2022 | -25.16% |
| Q4 2021 | -39.09% |
| Q3 2021 | -70.51% |
| Q2 2021 | -2.38% |
| Q1 2021 | -122.86% |
| Q4 2020 | 64.11% |
| Q3 2020 | -356.00% |
| Q2 2020 | 138.75% |
| Q1 2020 | 17.88% |
| Q4 2019 | 18.03% |
| Q3 2019 | -57.09% |
| Q2 2019 | 25.38% |
| Q1 2019 | -55.47% |
| Q4 2018 | -4.08% |
| Q3 2018 | 22.17% |
| Q2 2018 | -39.81% |
| Q1 2018 | -169.91% |
| Q4 2017 | 63.58% |
| Q3 2017 | -21.76% |
| Q2 2017 | -2.15% |
| Q1 2017 | -85.93% |
| Q4 2016 | 55.66% |
| Q3 2016 | -24.86% |
| Q2 2016 | -55.43% |
| Q1 2016 | 43.14% |
| Q4 2015 | 1.78% |